Increased Prolactin Levels During Reserpine Treatment of Hypertensive Patients

Peter A. Lee, Michael R. Kelly, John D. Wallin

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Serum prolactin levels are significantly greater among hypertensive patients receiving reserpine as compared to levels six weeks after discontinuing the treatment (P <.005). This association between regular, longterm reserpine use and greater prolactin levels may be clinically significant, since an increased incidence of breast cancer has been reported among hypertensive patients receiving reserpine.

Original languageEnglish (US)
Pages (from-to)2316-2317
Number of pages2
JournalJAMA: The Journal of the American Medical Association
Volume235
Issue number21
DOIs
StatePublished - May 24 1976

Fingerprint

Reserpine
Prolactin
Therapeutics
Breast Neoplasms
Incidence
Serum

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{21c75f30b1334a9e83eadc1f28d3c65b,
title = "Increased Prolactin Levels During Reserpine Treatment of Hypertensive Patients",
abstract = "Serum prolactin levels are significantly greater among hypertensive patients receiving reserpine as compared to levels six weeks after discontinuing the treatment (P <.005). This association between regular, longterm reserpine use and greater prolactin levels may be clinically significant, since an increased incidence of breast cancer has been reported among hypertensive patients receiving reserpine.",
author = "Lee, {Peter A.} and Kelly, {Michael R.} and Wallin, {John D.}",
year = "1976",
month = "5",
day = "24",
doi = "10.1001/jama.1976.03260470034022",
language = "English (US)",
volume = "235",
pages = "2316--2317",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "21",

}

Increased Prolactin Levels During Reserpine Treatment of Hypertensive Patients. / Lee, Peter A.; Kelly, Michael R.; Wallin, John D.

In: JAMA: The Journal of the American Medical Association, Vol. 235, No. 21, 24.05.1976, p. 2316-2317.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Increased Prolactin Levels During Reserpine Treatment of Hypertensive Patients

AU - Lee, Peter A.

AU - Kelly, Michael R.

AU - Wallin, John D.

PY - 1976/5/24

Y1 - 1976/5/24

N2 - Serum prolactin levels are significantly greater among hypertensive patients receiving reserpine as compared to levels six weeks after discontinuing the treatment (P <.005). This association between regular, longterm reserpine use and greater prolactin levels may be clinically significant, since an increased incidence of breast cancer has been reported among hypertensive patients receiving reserpine.

AB - Serum prolactin levels are significantly greater among hypertensive patients receiving reserpine as compared to levels six weeks after discontinuing the treatment (P <.005). This association between regular, longterm reserpine use and greater prolactin levels may be clinically significant, since an increased incidence of breast cancer has been reported among hypertensive patients receiving reserpine.

UR - http://www.scopus.com/inward/record.url?scp=0017314633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017314633&partnerID=8YFLogxK

U2 - 10.1001/jama.1976.03260470034022

DO - 10.1001/jama.1976.03260470034022

M3 - Article

C2 - 131202

AN - SCOPUS:0017314633

VL - 235

SP - 2316

EP - 2317

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 21

ER -